Searched for
REGULATORY BIOLOGY LABORATORY
'Threat of biological weapons no longer a theoretical concern': EAM JaishankarIndia's External Affairs Minister S Jaishankar highlighted the growing threat of biological weapons and bioterrorism. He stressed the urgen...02 Dec, 2025, 12.36 AM IST- Biocon shares rise 2% after USFDA concludes inspection with 5 observationsBiocon shares: The inspection, carried out from August 26 to September 3, 2025, spanned multiple operational areas such as drug substance m...05 Sep, 2025, 10.30 AM IST
- Dr Reddy's Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancerDr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic nasopharyngeal carcinoma ...29 Nov, 2024, 10.15 AM IST
- Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinomaDr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (N...28 Nov, 2024, 11.45 AM IST
- DCGI to accept toxicity data approved in other countries for drug reviewAnimal toxicity data generated in other nations is likely to be accepted, and the regulator may not seek fresh tests in India on a case-to-...03 Aug, 2024, 12.23 AM IST
- Biocon Biologics' Malaysia insulin facility classified by US FDA for official actionBiocon Biologics has announced that its insulin manufacturing facility in Johor, Malaysia has been classified as an official action indicat...18 Oct, 2023, 12.36 PM IST
- Biocon Biologics gets eight observations from USFDA for Malaysia insulin facilityThe US drug regulator issued 6 observations for drug substance, drug product units and quality Control laboratories and 2 observations for ...21 Jul, 2023, 10.40 PM IST
- Dr Reddy's application for biosimilar candidate accepted for review by USFDARituximab is used to treat certain autoimmune diseases and types of cancer. "This milestone underscores our capability for global clinical ...12 Jul, 2023, 09.02 PM IST
- Dr Reddy's Lab completes Phase 1 study of proposed arthritis drugDr Reddy's Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be ...19 Dec, 2022, 02.07 PM IST
- Allegations 'serious' & 'grave', says special court in Biocon Biologics caseThe special CBI court, in an 80-page order rejecting the bail pleas of all five accused in the case earlier this week, said: "The questions...23 Jul, 2022, 05.58 AM IST
- Biocon Biologics gets EU GMP certification from Ireland's HPRAThe company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certif...05 Jul, 2022, 07.53 PM IST
- Shilpa Medicare zooms 26% in 2 days after DRL vaccine dealIn five consecutive sessions, the counter has surged 30 per cent.18 May, 2021, 12.36 PM IST
- Shilpa Medicare jumps 12% after inking vaccine deal with DRLThe company has entered into a three-year agreement with Dr Reddy's Laboratories Limited (DRL) for the production of Sputnik V vaccine for ...17 May, 2021, 04.16 PM IST
- Shilpa Medicare arm inks pact with Dr Reddy's to manufacture Sputnik V vaccine"The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr...17 May, 2021, 10.41 AM IST
- Now, eat right with an appTwo Indian-origin scientists have designed an app to help users improve their erratic eating habits and lose weight.25 Sep, 2015, 05.12 PM IST
- CCEA approves proposal for strengthening drug regulatory systemCabinet Committee on Economic Affairs (CCEA) approved a proposal for strengthening and upgrading the drug regulatory system both at the Cen...12 Aug, 2015, 11.15 PM IST
- DRL to launch biosimilar drugs in Europe by '10India's largest drug maker, Dr Reddy’s Laboratories, is planning to introduce its first biosimilar drug by 2010 in Europe, a senior company...09 Oct, 2007, 02.57 AM IST
Load More
